148 related articles for article (PubMed ID: 33725031)
1. Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity.
Gabano E; Rangone B; Perin E; Caron G; Ermondi G; Vallaro M; Gandin V; Marzano C; Barbanente A; Margiotta N; Ravera M
Dalton Trans; 2021 Apr; 50(13):4663-4672. PubMed ID: 33725031
[TBL] [Abstract][Full Text] [Related]
2. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
[TBL] [Abstract][Full Text] [Related]
3. Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer.
Sabbatini M; Zanellato I; Ravera M; Gabano E; Perin E; Rangone B; Osella D
J Med Chem; 2019 Apr; 62(7):3395-3406. PubMed ID: 30879295
[TBL] [Abstract][Full Text] [Related]
4. Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP-1.
Xu Z; Hu W; Wang Z; Gou S
Eur J Med Chem; 2017 Dec; 141():211-220. PubMed ID: 29031068
[TBL] [Abstract][Full Text] [Related]
5. Platinum(IV) combo prodrugs containing cyclohexane-1
Gabano E; Gariboldi MB; Marras E; Barbato F; Ravera M
Dalton Trans; 2023 Aug; 52(32):11349-11360. PubMed ID: 37530512
[TBL] [Abstract][Full Text] [Related]
6. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
[TBL] [Abstract][Full Text] [Related]
7. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
9. Mono-carboxylated diaminedichloridoplatinum(IV) complexes--selective synthesis, characterization, and cytotoxicity.
Pichler V; Valiahdi SM; Jakupec MA; Arion VB; Galanski MS; Keppler BK
Dalton Trans; 2011 Aug; 40(32):8187-92. PubMed ID: 21743934
[TBL] [Abstract][Full Text] [Related]
10. Pyrimidinedione-mediated selective histone deacetylase 6 inhibitors with antitumor activity in colorectal cancer HCT116 cells.
Liu YM; Lee HY; Lai MJ; Pan SL; Huang HL; Kuo FC; Chen MC; Liou JP
Org Biomol Chem; 2015 Oct; 13(40):10226-35. PubMed ID: 26309122
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
Cheng C; Yun F; He J; Ullah S; Yuan Q
Eur J Med Chem; 2019 Jul; 173():185-202. PubMed ID: 31003060
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors.
Thaler F; Varasi M; Abate A; Carenzi G; Colombo A; Bigogno C; Boggio R; Zuffo RD; Rapetti D; Resconi A; Regalia N; Vultaggio S; Dondio G; Gagliardi S; Minucci S; Mercurio C
Eur J Med Chem; 2013 Jun; 64():273-84. PubMed ID: 23644210
[TBL] [Abstract][Full Text] [Related]
13. A new platinum-bromine cyclohexanediamine complex from the family of cancer cytostatics.
Pazout R; Maixner J; Holakovská J; Dušek M; Kačer P
Acta Crystallogr C; 2012 Dec; 68(Pt 12):m340-3. PubMed ID: 23221243
[TBL] [Abstract][Full Text] [Related]
14. Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities.
Chen Y; Wang X; Xiang W; He L; Tang M; Wang F; Wang T; Yang Z; Yi Y; Wang H; Niu T; Zheng L; Lei L; Li X; Song H; Chen L
J Med Chem; 2016 Jun; 59(11):5488-504. PubMed ID: 27186676
[TBL] [Abstract][Full Text] [Related]
15. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological studies of pyrazolyl-diamine Pt(II) complexes containing polyaromatic DNA-binding groups.
Gama S; Mendes F; Esteves T; Marques F; Matos A; Rino J; Coimbra J; Ravera M; Gabano E; Santos I; Paulo A
Chembiochem; 2012 Nov; 13(16):2352-62. PubMed ID: 23038670
[TBL] [Abstract][Full Text] [Related]
17. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
[TBL] [Abstract][Full Text] [Related]
18. Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells.
Zhang K; Yao Y; Tu Z; Liao C; Wang Z; Qiu Y; Chen D; Hamilton DJ; Li Z; Jiang S
Future Med Chem; 2020 Feb; 12(4):311-323. PubMed ID: 31782319
[No Abstract] [Full Text] [Related]
19. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of novel POLA1-HDAC11 dual inhibitors.
Dallavalle S; Musso L; Cincinelli R; Darwiche N; Gervasoni S; Vistoli G; Guglielmi MB; La Porta I; Pizzulo M; Modica E; Prosperi F; Signorino G; Colelli F; Cardile F; Fucci A; D'Andrea EL; Riccio A; Pisano C
Eur J Med Chem; 2022 Jan; 228():113971. PubMed ID: 34772529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]